Health News Archive - May 14, 2009
According to a report in the health journal Obesity, scientists examining the efficacy of public health campaigns against obesity have discovered that such programs may result in the opposite of the intended effect.
NEWTOWN SQUARE, Pa., May 14 /PRNewswire/ -- The Philadelphia area-based probiotics firm Kibow Biotech will be one of only three (3) Pennsylvania companies invited to present at the BIO 2009 Company Forum, http://www.convention.bio.org, in Atlanta, GA on Tuesday, May 19.
VEENENDAAL, The Netherlands, May 14 /PRNewswire/ -- Nucletron, a knowledge-based leader in radiation oncology, today announced a new release of Oncentra(R) Brachy, a comprehensive film- and volume-based treatment planning system to optimize cancer treatment planning for brachytherapy. Oncentra Brachy, the world's first fully DICOM-compatible treatment planning system, is a user-friendly Windows-based planning system that features state-of-the-art optimization algorithms to ensure efficient treatment. Oncentra Brachy is adaptable to any clinical workflow.
Insurance Regulators Offer Tips, Information for Consumers KANSAS CITY, Mo., May 14 /PRNewswire/ -- With the national unemployment rate at 8.5 percent,(1) families are living on tighter budgets, and many are struggling to maintain their health insurance coverage.
Recommends Four Tips for Women's Hearing Loss Prevention PISCATAWAY, N.J., May 14 /PRNewswire/ -- Siemens Hearing Instruments, Inc. (SHI) celebrates the 10th Annual National Women's Health Week, a weeklong observance from May 10 - 16, 2009. Coordinated by the U.S.
Platform Technology, QTinno(TM) and Visual3Dx(TM) to be introduced at prestigious conference Information located at booth 468 SANTA CLARA, Calif., May 14 /PRNewswire-FirstCall/ -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic and services company, today announced that the Company will introduce the NewCardio platform, QTinno(TM) and Visual3Dx(TM) at Heart Rhythm 2009, today through May 16, 2009.
BURLINGTON, Mass., May 14 /PRNewswire-FirstCall/ -- Palomar Medical Technologies, Inc.
FREMONT, Calif., May 14 /PRNewswire/ -- Quark Pharmaceuticals, Inc., a development-stage pharmaceutical company discovering and developing novel RNA interference (RNAi)-based therapeutics, today announced that Elena Feinstein, M.D., Ph.D., Chief Scientific Officer, presented a study titled, "siRNA Therapeutics for Prevention of Ocular and Inner Ear Sensory Cells Death," at the DxRx Summit: Nucleic Acid Diagnostics & Therapeutics.
BrachyVision Acuros Enables Superior Dose Calculation with Unmatched Speed CHARLOTTESVILLE, Va., May 14 /PRNewswire-FirstCall/ -- A significantly more accurate* way of calculating the dosimetry of cancer treatments will be introduced by Varian Medical Systems (NYSE: VAR) at the GEC-ESTRO exhibition in Porto, Portgual, on May 14-16.
- "BioMS/Eli Lilly - Dissecting a Billion Dollar Collaboration" - Toronto Stock Exchange Symbol: MS EDMONTON, May 14 /PRNewswire-FirstCall/ - BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that Mr.